Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

More Power to OATP1B1: An Evaluation of Sample Size in Pharmacogenetic Studies Using a Rosuvastatin PBPK Model for Intestinal, Hepatic, and Renal Transporter‐Mediated Clearances
Ariane Emami Riedmaier, Howard Burt, Khaled Abduljalil, et al.
The Journal of Clinical Pharmacology (2016) Vol. 56, Iss. S7
Open Access | Times Cited: 25

Showing 25 citing articles:

Physiologically‐Based Pharmacokinetic Models for Evaluating Membrane Transporter Mediated Drug–Drug Interactions: Current Capabilities, Case Studies, Future Opportunities, and Recommendations
Kunal S. Taskar, Venkatesh Pilla Reddy, Howard Burt, et al.
Clinical Pharmacology & Therapeutics (2019) Vol. 107, Iss. 5, pp. 1082-1115
Open Access | Times Cited: 119
Abundance of Hepatic Transporters in Caucasians: A Meta-Analysis
Howard Burt, Arian Emami Riedmaier, Matthew D. Harwood, et al.
Drug Metabolism and Disposition (2016) Vol. 44, Iss. 10, pp. 1550-1561
Open Access | Times Cited: 65
Development of a Dynamic Physiologically Based Mechanistic Kidney Model to Predict Renal Clearance
Weize Huang, Nina Isoherranen
CPT Pharmacometrics & Systems Pharmacology (2018) Vol. 7, Iss. 9, pp. 593-602
Open Access | Times Cited: 46
A Comprehensive Framework for Physiologically‐Based Pharmacokinetic Modeling in Matlab
Felix Stader, Melissa A. Penny, Marco Siccardi, et al.
CPT Pharmacometrics & Systems Pharmacology (2019) Vol. 8, Iss. 7, pp. 444-459
Open Access | Times Cited: 41
A Review of Physiologically-based Pharmacokinetic (PBPK) Modeling of Renal Drug Disposition
Weize Huang, Christine M. Bowman, Mengyue Yin, et al.
Drug Metabolism and Disposition (2025) Vol. 53, Iss. 3, pp. 100042-100042
Open Access
Systematic Development and Verification of a Physiologically Based Pharmacokinetic Model of Rivaroxaban
Eleanor Jing Yi Cheong, Denise Wun Xi Teo, Denise Xin Yi Chua, et al.
Drug Metabolism and Disposition (2019) Vol. 47, Iss. 11, pp. 1291-1306
Open Access | Times Cited: 26
Proteomics‐Informed Prediction of Rosuvastatin Plasma Profiles in Patients With a Wide Range of Body Weight
Christine Wegler, Luna Prieto Garcia, Signe Klinting, et al.
Clinical Pharmacology & Therapeutics (2020) Vol. 109, Iss. 3, pp. 762-771
Open Access | Times Cited: 22
A permeability‐ and perfusion‐based PBPK model for improved prediction of concentration‐time profiles
Ken Korzekwa, Casey Radice, Swati Nagar
Clinical and Translational Science (2022) Vol. 15, Iss. 8, pp. 2035-2052
Open Access | Times Cited: 14
Mechanistic evaluation of the inhibitory effect of four SGLT-2 inhibitors on SGLT 1 and SGLT 2 using physiologically based pharmacokinetic (PBPK) modeling approaches
Yu Zhang, Panpan Xie, Yamei Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Understanding Statin‐Roxadustat Drug–Drug‐Disease Interaction Using Physiologically‐Based Pharmacokinetic Modeling
Jin Dong, Luna Prieto Garcia, Yingbo Huang, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 4, pp. 825-835
Open Access | Times Cited: 6
Effect of OATP1B1 genetic polymorphism on the uptake of tamoxifen and its metabolite, endoxifen
Chunmei Gao, Zhichen Pu, Chunyuan He, et al.
Oncology Reports (2017) Vol. 38, Iss. 2, pp. 1124-1132
Open Access | Times Cited: 17
Research Progress of Herbal Medicines on Drug Metabolizing Enzymes: Consideration Based on Toxicology
Shuting Wang, Wanfang Li, Jianbo Yang, et al.
Current Drug Metabolism (2020) Vol. 21, Iss. 12, pp. 913-927
Closed Access | Times Cited: 13
Assessment of OATP transporter‐mediated drug–drug interaction using physiologically‐based pharmacokinetic (PBPK) modeling – a case example
Yuan Chen, Rui Zhu, Fang Ma, et al.
Biopharmaceutics & Drug Disposition (2018) Vol. 39, Iss. 9, pp. 420-430
Closed Access | Times Cited: 14
Examination of Physiologically‐Based Pharmacokinetic Models of Rosuvastatin
Christine M. Bowman, Fang Ma, Jialin Mao, et al.
CPT Pharmacometrics & Systems Pharmacology (2020) Vol. 10, Iss. 1, pp. 5-17
Open Access | Times Cited: 12
Is Ethnic Variability in the Exposure to Rosuvastatin Explained Only by Genetic Polymorphisms in OATP1B1 and BCRP or Should the Contribution of Intrinsic Ethnic Differences in OATP1B1 Be Considered?
Yuichi Sugiyama, Kazuya Maeda, Kota Toshimoto
Journal of Pharmaceutical Sciences (2017) Vol. 106, Iss. 9, pp. 2227-2230
Open Access | Times Cited: 10
Role of Transporters in Drug Development
Vikram Arya, Jennifer J. Kiser
The Journal of Clinical Pharmacology (2016) Vol. 56, Iss. S7
Open Access | Times Cited: 9
Unequivocal evidence supporting the segregated flow intestinal model that discriminates intestine versus liver first‐pass removal with PBPK modeling
K. Sandy Pang, Qi Joy Yang, Keumhan Noh
Biopharmaceutics & Drug Disposition (2016) Vol. 38, Iss. 3, pp. 231-250
Closed Access | Times Cited: 9
Improving the Translation of Organic Anion Transporting Polypeptide Substrates using HEK293 Cell Data in the Presence and Absence of Human Plasma via PBPK Modeling
Christine M. Bowman, Buyun Chen, Jonathan Cheong, et al.
Drug Metabolism and Disposition (2021), pp. DMD-000315
Open Access | Times Cited: 7
A Prediction Method for P-glycoprotein–Mediated Drug–Drug Interactions at the Human Blood–Brain Barrier From Blood Concentration–Time Profiles, Validated With PET Data
Akihiro MATSUDA, Rudolf Karch, Martin Bauer, et al.
Journal of Pharmaceutical Sciences (2017) Vol. 106, Iss. 9, pp. 2780-2786
Open Access | Times Cited: 4
The pharmacogenetics of OATP1B1 variants and their impact on the pharmacokinetics and efficacy of elbasvir/grazoprevir
Zifang Guo, Luzelena Caro, Michael Robertson, et al.
Pharmacogenomics (2019) Vol. 20, Iss. 9, pp. 631-641
Closed Access | Times Cited: 4
Mechanistic Account of Distinct Change in Organic Anion Transporting Polypeptide 1B (OATP1B) Substrate Pharmacokinetics during OATP1B-Mediated Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling
Pooja Hegde, Bridget L. Morse
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 8, pp. 886-898
Open Access
The Genetic Blueprint of Cardiovascular Therapy: Pharmacogenomics for Improved Efficacy and Safety
Nikhilesh Andhi, Bhuvana Darawadi
Journal of Indian College of Cardiology (2024) Vol. 14, Iss. 3, pp. 79-87
Open Access
A mechanistic model to study the kinetics and toxicity of salicylic acid in the kidney of four virtual individuals
Julia Pletz, Terry J. Allen, Judith C. Madden, et al.
Computational Toxicology (2021) Vol. 19, pp. 100172-100172
Closed Access | Times Cited: 3
APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC AND PHARMACODYNAMIC (PBPK/PD) MODELING COMPRISING TRANSPORTERS
Matthew D. Harwood, Amin Rostami‐Hodjegan, Sibylle Neuhoff
(2022), pp. 475-496
Closed Access | Times Cited: 1
PBPK modeling for early clinical study decision making
Arian Emami Riedmaier
Elsevier eBooks (2023), pp. 293-304
Closed Access
Page 1

Scroll to top